Genetics of intermediate phenotypes;Genetik intermediärer phänotypen

Medizinische Genetik

Volumn 19, Issue 3, 2007, Pages 304-308

  Kronenberg, F ^a   Heid, I M ^b,c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Association study; Intermediate phenotype; Mendelian randomization; Polymorphism; Quantitative phenotype

Indexed keywords

ASTHMA; ATOPY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HERITABILITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; SCHIZOPHRENIA; SHORT SURVEY;

EID: 42049098830     PISSN: 09365931     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11825-007-0036-0     Document Type: Short Survey

References (16)

1. Baron RM, Kenny DA (1986) The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51: 1173-1182
2. Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest [Suppl 3] 32: 14-23
3. Contopoulos-Ioannidis DG, Kouri IN, Ioannidis JP (2007) Genetic predisposition to asthma and atopy. Respiration 74: 8-12
4. Davey SG, Ebrahim S (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1-22
5. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645
6. Heid IM, Wagner SA, Gohlke H et al. (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians. Diabetes 55: 375-384
7. Huth C, Heid IM, Vollmert C et al. (2006) IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes 55: 2915-2921
8. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846
9. Katan MB (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1: 507-508
10. Kronenberg F, Coon H, Gutin A et al. (2002) A genome scan for loci influencing anti-atherogenic serum bilirubin levels. Eur J Hum Genet 10: 539-546
11. Lin J-P, O'Donnell CJ, Schwaiger JP et al. (2006) Association between UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 114: 1476-1481
12. Palmer LJ, Redline S (2003) Genomic approaches to understanding obstructive sleep apnea. Respir Physiol Neurobiol 135: 187-205
13. Prentice RL (1989) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8: 431-440
14. Sandholzer C, Saha N, Kark JD et al. (1992) Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb 12: 1214-1226
15. Schoenborn V, Heid IM, Vollmert C et al. (2006) The ATGL gene is associated with free fatty acids, triglycerides and type 2 diabetes. Diabetes 55: 1270-1275
16. Zimmermann R, Strauss JG, Haemmerle G et al. (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306: 1383-1386